DXP Enterprises, Inc. (NASDAQ:DXPE) today announced that David Little, Chairman and CEO of DXP and Mac McConnell, Senior Vice President and Chief Financial Officer of DXP, will present at the Stephens Inc. Fall Investment Conference. The conference will be held November 18 & 19, 2008 at The New York Palace Hotel in New York City. DXP is scheduled to present on November 18, 2008 at 10:00 a.m. and will be available for one-on-one meetings following their presentation.
The presentation will be webcast and will be available at http://www.wsw.com/webcast/stph9/dxpe/ and at www.dxpe.com for approximately 90 days.
DXP’s innovative pumping solutions provide engineering, fabrication and technical design to meet the capital equipment needs of its global customer base. DXP provides solutions by utilizing manufacturer authorized equipment and certified personnel. Pump packages require MRO and OEM equipment such as pumps, motors and valves, and consumable products. DXP leverages its MROP inventories and technical knowledge to lower the total cost and maintain the quality of the pump package.
SmartSource, a DXP integrated supply program, allows a more efficient way to manage the customer’s supply chain needs for MROP products. The program allows the customer to transfer all or part of its supply chain needs to DXP, so the customer can focus on its core business. SmartSource effectively lowers costs by outsourcing purchasing, accounting, and on-site supply management to DXP, which reduces the duplication of effort by the customer and supplier. DXP’s broad range of first-tier products provides an efficient measurable solution to reduce cost and streamline procurement and sourcing operations.
The Private Securities Litigation Reform Act of 1995 provides a “safe-harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made by or to be made by the Company) contains statements that are forward-looking. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future; and accordingly, such results may differ from those expressed in any forward-looking statement made by or on behalf of the Company. These risks and uncertainties include, but are not limited to; ability to obtain needed capital, dependence on existing management, leverage and debt service, domestic or global economic conditions, and changes in customer preferences and attitudes. For more information, review the Company's filings with the Securities and Exchange Commission.
Recent DXPE News
- DXP Sets Date for 2024 First Quarter Earnings Release and Conference Call • Business Wire • 05/03/2024 07:21:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:57:02 PM
- DXP Enterprises Reports Fourth Quarter and Fiscal 2023 Results • Business Wire • 03/07/2024 02:15:00 PM
- DXP Enterprises, Inc. Announces Acquisition of Pro-Seal, Inc. • Business Wire • 03/05/2024 02:00:00 PM
- DXP Sets Date for 2023 Fourth Quarter and Year End Earnings Release and Conference Call • Business Wire • 03/04/2024 07:43:00 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 07:31:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 07:51:40 PM
- DXP Enterprises, Inc. Announces Acquisition of Kappe Associates, Inc. • Business Wire • 02/05/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 04:52:32 PM
- DXP Enterprises, Inc. Completes Strategic Acquisition • Business Wire • 01/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 07:41:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM